BLOOD LIVER ENZYME LEVELS CORRELATE WITH HEPATIC TUMOR BURDEN IN ADVANCED NEUROENDOCRINE TUMORS

被引：0
|
作者：
Chen, Luohai
Jumai, Nuerailaguli
Liu, Man
He, Qiao
Lin, Yuan
Luo, Yanji
Wang, Yu
Zhang, Xiangsong
Chen, Minhu
Zeng, Zhirong
Zhang, Ning
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
neuroendocrine tumors; hepatic tumor burden; liver enzyme; overall survival;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EP26
引用
收藏
页码：S1193 / S1193
页数：1
相关论文
共 50 条
  • [1] Blood liver enzyme levels correlate with hepatic tumor burden in advanced neuroendocrine tumors
    Chen, L.
    Jumai, N.
    Liu, M.
    He, Q.
    Lin, Y.
    Luo, Y.
    Wang, Y.
    Zhang, X.
    Chen, M. H.
    Zeng, Z.
    Zhang, N.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 133 - 133
  • [2] Chromogranin A (CgA) serum levels correlate with hepatic tumor burden in patients with neuroendocrine gastroenteropancreatic (GEP) tumors
    Rinke, A
    Wilke, A
    Mayer, C
    Scherag, A
    Klose, KJ
    Arnold, R
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 45 - 45
  • [3] Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors?
    Schmidt, Benjamin Christopher
    Leiderer, Miriam Theresa
    Amin, Tania
    Viol, Fabrice
    Huber, Samuel
    Henes, Frank Oliver
    Schrader, Joerg
    ENDOCRINE, 2024, 83 (02) : 511 - 518
  • [4] Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors?
    Benjamin Christopher Schmidt
    Miriam Theresa Leiderer
    Tania Amin
    Fabrice Viol
    Samuel Huber
    Frank Oliver Henes
    Jörg Schrader
    Endocrine, 2024, 83 : 511 - 518
  • [5] Gamma-glutamyltransferase as an indicator of hepatic tumor burden in neuroendocrine tumors
    Schmidt, B.
    Leiderer, M.
    Amin, T.
    Viol, F.
    Adam, G.
    Huber, S.
    Henes, F. O.
    Schrader, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 118 - 118
  • [6] Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis
    Khasraw, Mustafa
    Gill, Anthony
    Harrington, Tim
    Pavlakis, Nick
    Modlin, Irvin
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (09) : 838 - 847
  • [7] Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Kitano, Mio
    Davidson, Gail W.
    Shirley, Lawrence A.
    Schmidt, Carl R.
    Guy, Gregory E.
    Khabiri, Hooman
    Dowell, Joshua D.
    Shah, Manisha H.
    Bloomston, Mark
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 4008 - 4015
  • [8] Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Mio Kitano
    Gail W. Davidson
    Lawrence A. Shirley
    Carl R. Schmidt
    Gregory E. Guy
    Hooman Khabiri
    Joshua D. Dowell
    Manisha H. Shah
    Mark Bloomston
    Annals of Surgical Oncology, 2016, 23 : 4008 - 4015
  • [9] Serum Chromogranin A is a Predictor for Liver Metastatic Tumor Burden and Therapeutic Response in Advanced Non-Functional Pancreatic Neuroendocrine Tumors
    Zhang, C.
    Han, X.
    Tang, M.
    Ji, Y.
    Pan, B.
    Lou, W.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 258 - 259
  • [10] Transarterial Chemoembolization (TACE) of Liver Metastases Derived from Neuroendocrine Tumors is an Effective Treatment only in Patients with Low or Mediate Hepatic Tumor Burden
    Rinke, A.
    Koenig, A.
    Mueller, D.
    Koenig, U.
    Gress, T.
    Burbelko, M.
    Kalinowski, M.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 55 - 55
12345